Shi, Q., Paiva, B., Pederson, L. D., Dimier, N., Talpes, E., Prior, T. J., Orfao, A., Moreau, P., Sonneveld, P., Kumar, S. K., Dixon, J. G., Patel, R., Bartlett, B. J., Schecter, J., McCarthy, P., Hose, D., Seckinger, A., Mattia, D., Goldschmidt, H., Oliva, S., Owen, R. G., Anderson, K. C., San-Miguel, J., Durie, B. G., Munshi, N. (2025). Minimal Residual Disease–Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02020